Through interference experiments in vitro, our results indicated that MAP3K4 might be involved in the biogenesis of LDs by regulating the phosphorylation of JNK and cPLA2 in NAFLD. Here, MAP3K4 is linked to metabolic dysfunction-associated steatotic liver disease.